You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT JAMA
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 285 No. 18, May 9, 2001 TABLE OF CONTENTS
  JAMA
  •  Online Features
  Clinical Cardiology
 This Article
 •Full text
 •PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on Web of Science (646)
 •Contact me when this article is cited
 Related Content
 •Related letter
 •Related article
 •Similar articles in JAMA
 Topic Collections
 •Cardiovascular System
 •Arrhythmias
 •Alert me on articles by topic
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Prevalence of Diagnosed Atrial Fibrillation in Adults

National Implications for Rhythm Management and Stroke Prevention: the AnTicoagulation and Risk Factors In Atrial Fibrillation (ATRIA) Study

Alan S. Go, MD; Elaine M. Hylek, MD,MPH; Kathleen A. Phillips, BA; YuChiao Chang, PhD; Lori E. Henault, MPH; Joe V. Selby, MD,MPH; Daniel E. Singer, MD

JAMA. 2001;285:2370-2375.

Context  Atrial fibrillation is the most common arrhythmia in elderly persons and a potent risk factor for stroke. However, recent prevalence and projected future numbers of persons with atrial fibrillation are not well described.

Objective  To estimate prevalence of atrial fibrillation and US national projections of the numbers of persons with atrial fibrillation through the year 2050.

Design, Setting, and Patients  Cross-sectional study of adults aged 20 years or older who were enrolled in a large health maintenance organization in California and who had atrial fibrillation diagnosed between July 1, 1996, and December 31, 1997.

Main Outcome Measures  Prevalence of atrial fibrillation in the study population of 1.89 million; projected number of persons in the United States with atrial fibrillation between 1995-2050.

Results  A total of 17 974 adults with diagnosed atrial fibrillation were identified during the study period; 45% were aged 75 years or older. The prevalence of atrial fibrillation was 0.95% (95% confidence interval, 0.94%-0.96%). Atrial fibrillation was more common in men than in women (1.1% vs 0.8%; P<.001). Prevalence increased from 0.1% among adults younger than 55 years to 9.0% in persons aged 80 years or older. Among persons aged 50 years or older, prevalence of atrial fibrillation was higher in whites than in blacks (2.2% vs 1.5%; P<.001). We estimate approximately 2.3 million US adults currently have atrial fibrillation. We project that this will increase to more than 5.6 million (lower bound, 5.0; upper bound, 6.3) by the year 2050, with more than 50% of affected individuals aged 80 years or older.

Conclusions  Our study confirms that atrial fibrillation is common among older adults and provides a contemporary basis for estimates of prevalence in the United States. The number of patients with atrial fibrillation is likely to increase 2.5-fold during the next 50 years, reflecting the growing proportion of elderly individuals. Coordinated efforts are needed to face the increasing challenge of optimal stroke prevention and rhythm management in patients with atrial fibrillation.


Author Affiliations: Division of Research, Kaiser Permanente of Northern California, Oakland (Drs Go and Selby and Ms Phillips); Departments of Epidemiology, Biostatistics, and Medicine, University of California at San Francisco (Dr Go); Clinical Epidemiology Unit, General Medicine Division, Department of Medicine, Massachusetts General Hospital and Harvard Medical School, Boston (Drs Hylek, Chang, and Singer, and Ms Henault).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

RELATED LETTER

Use of Amiodarone
John R. Kapoor
JAMA. 2007;298(22):2617.
EXTRACT | FULL TEXT  

RELATED ARTICLE

May 9, 2001
JAMA. 2001;285(18):2393-2394.
EXTRACT | FULL TEXT  


THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Image Quality of Coronary 320-MDCT in Patients With Atrial Fibrillation: Initial Experience
Pasricha et al.
Am. J. Roentgenol. 2009;193:1514-1521.
ABSTRACT | FULL TEXT  

Blood Pressure and Stroke in Heart Failure in the REasons for Geographic And Racial Differences in Stroke (REGARDS) Study
Pullicino et al.
Stroke 2009;40:3706-3710.
ABSTRACT | FULL TEXT  

Atrial Fibrillation at Baseline and During Follow-Up in ALLHAT (Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial).
Haywood et al.
J Am Coll Cardiol 2009;54:2023-2031.
ABSTRACT | FULL TEXT  

Optimal Anticoagulation Therapy in Patients With Valvular Heart Disease or Atrial Fibrillation
McLeod and Gersh
Arch Intern Med 2009;169:2032-2033.
FULL TEXT  

Efficacy of circumferential pulmonary vein ablation of atrial fibrillation in endurance athletes
Calvo et al.
Europace 2009;0:eup320v1-eup320.
ABSTRACT | FULL TEXT  

Atrial Arrhythmias in Adults With Congenital Heart Disease
Bouchardy et al.
Circulation 2009;120:1679-1686.
ABSTRACT | FULL TEXT  

Cracking the Mysteries of Diastolic Function in Atrial Fibrillation: New Technology for an Old Problem
Popovic and Klein
J Am Coll Cardiol Img 2009;2:1157-1158.
FULL TEXT  

Influence of different remifentanil concentrations on the performance of the surgical stress index to detect a standardized painful stimulus during sevoflurane anaesthesia
Gruenewald et al.
Br J Anaesth 2009;103:586-593.
ABSTRACT | FULL TEXT  

Independent Contribution of Diabetes to Increased Prevalence and Incidence of Atrial Fibrillation
Nichols et al.
Diabetes Care 2009;32:1851-1856.
ABSTRACT | FULL TEXT  

Quality of care for atrial fibrillation among patients hospitalized for heart failure.
Piccini et al.
J Am Coll Cardiol 2009;54:1280-1289.
ABSTRACT | FULL TEXT  

New Therapies for Stroke Prevention in Atrial Fibrillation: The Long Road to Enhanced Efficacy
Freedman and Gersh
Circulation 2009;120:1024-1026.
FULL TEXT  

Comparative efficacy of dronedarone and amiodarone for the maintenance of sinus rhythm in patients with atrial fibrillation.
Piccini et al.
J Am Coll Cardiol 2009;54:1089-1095.
ABSTRACT | FULL TEXT  

Cost-Effectiveness of Genotype-Guided Warfarin Dosing for Patients With Atrial Fibrillation
Patrick et al.
Circ Cardiovasc Qual Outcomes 2009;2:429-436.
ABSTRACT | FULL TEXT  

Is rate more important than rhythm in treating atrial fibrillation? No
Mitchell
BMJ 2009;339:b3174-b3174.
FULL TEXT  

Dronedarone
Patel et al.
Circulation 2009;120:636-644.
ABSTRACT | FULL TEXT  

Randomized study of surgical isolation of the pulmonary veins for correction of permanent atrial fibrillation associated with mitral valve disease.
Albrecht et al.
J. Thorac. Cardiovasc. Surg. 2009;138:454-459.
ABSTRACT | FULL TEXT  

Cost-Effectiveness of Radiofrequency Catheter Ablation Compared With Antiarrhythmic Drug Therapy for Paroxysmal Atrial Fibrillation
Reynolds et al.
Circ Arrhythm Electrophysiol 2009;2:362-369.
ABSTRACT | FULL TEXT  

Targeting of cardiac autonomic plexus for modulation of intracardiac neural tone
Gemein et al.
Europace 2009;11:1090-1096.
ABSTRACT | FULL TEXT  

Percutaneous Closure of the Left Atrial Appendage: A Major Step Forward
Sievert and Bayard
J Am Coll Cardiol Intv 2009;2:601-602.
FULL TEXT  

Should Patient Characteristics Influence Target Anticoagulation Intensity for Stroke Prevention in Nonvalvular Atrial Fibrillation?: The ATRIA Study
Singer et al.
Circ Cardiovasc Qual Outcomes 2009;2:297-304.
ABSTRACT | FULL TEXT  

Contemporary Management of Atrial Fibrillation: Update on Anticoagulation and Invasive Management Strategies
Crandall et al.
Mayo Clin Proc. 2009;84:643-662.
ABSTRACT | FULL TEXT  

Perindopril decreases P wave dispersion in patients with stage 1 hypertension
Ozben et al.
Journal of Renin-Angiotensin-Aldosterone System 2009;10:85-90.
ABSTRACT  

Atrial fibrillation: cure or treat?
Forleo and Tondo
Ther Adv Cardiovasc Dis 2009;3:187-196.
ABSTRACT  

The ACTIVE Pursuit of Stroke Prevention in Patients with Atrial Fibrillation
Go
NEJM 2009;360:2127-2129.
FULL TEXT  

Atrial Fibrillation and Heart Failure: Treatment Considerations for a Dual Epidemic
Anter et al.
Circulation 2009;119:2516-2525.
FULL TEXT  

Middle-aged men with increased waist circumference and elevated C-reactive protein level are at higher risk for postoperative atrial fibrillation following coronary artery bypass grafting surgery
Girerd et al.
Eur Heart J 2009;30:1270-1278.
ABSTRACT | FULL TEXT  

Cost of Hospital Admission for Antiarrhythmic Drug Initiation in Atrial Fibrillation
Kim et al.
The Annals of Pharmacotherapy 2009;43:840-848.
ABSTRACT | FULL TEXT  

Assessment of left atrial appendage function with transthoracic tissue Doppler echocardiography
Uretsky et al.
Eur J Echocardiogr 2009;10:363-371.
ABSTRACT | FULL TEXT  

Influence of Systolic and Diastolic Blood Pressure on the Risk of Incident Atrial Fibrillation in Women
Conen et al.
Circulation 2009;119:2146-2152.
ABSTRACT | FULL TEXT  

Valsartan for Prevention of Recurrent Atrial Fibrillation
The GISSI-AF Investigators
NEJM 2009;360:1606-1617.
ABSTRACT | FULL TEXT  

Large scale replication and meta-analysis of variants on chromosome 4q25 associated with atrial fibrillation
Kaab et al.
Eur Heart J 2009;30:813-819.
ABSTRACT | FULL TEXT  

Pulmonary Vein Stenosis Complicating Ablation for Atrial Fibrillation: Clinical Spectrum and Interventional Considerations
Holmes et al.
J Am Coll Cardiol Intv 2009;2:267-276.
ABSTRACT | FULL TEXT  

The Registry of the German Competence NETwork on Atrial Fibrillation: patient characteristics and initial management
Nabauer et al.
Europace 2009;11:423-434.
ABSTRACT | FULL TEXT  

Effect of Age on Stroke Prevention Therapy in Patients With Atrial Fibrillation: The Atrial Fibrillation Investigators
van Walraven et al.
Stroke 2009;40:1410-1416.
ABSTRACT | FULL TEXT  

Ethnic Distribution of ECG Predictors of Atrial Fibrillation and Its Impact on Understanding the Ethnic Distribution of Ischemic Stroke in the Atherosclerosis Risk in Communities (ARIC) Study
Soliman et al.
Stroke 2009;40:1204-1211.
ABSTRACT | FULL TEXT  

Impact of Proteinuria and Glomerular Filtration Rate on Risk of Thromboembolism in Atrial Fibrillation: The Anticoagulation and Risk Factors in Atrial Fibrillation (ATRIA) Study
Go et al.
Circulation 2009;119:1363-1369.
ABSTRACT | FULL TEXT  

Role of Health Locus of Control Between Uncertainty and Uncertainty Appraisal Among Patients With Atrial Fibrillation
Kang
West J Nurs Res 2009;31:187-200.
ABSTRACT  

Effect of Dronedarone on Cardiovascular Events in Atrial Fibrillation
Hohnloser et al.
NEJM 2009;360:668-678.
ABSTRACT | FULL TEXT  

Prevention of Atrial Fibrillation: Report From a National Heart, Lung, and Blood Institute Workshop
Benjamin et al.
Circulation 2009;119:606-618.
ABSTRACT | FULL TEXT  

Trends in Postpartum Diabetes Screening and Subsequent Diabetes and Impaired Fasting Glucose Among Women With Histories of Gestational Diabetes Mellitus: A report from the Translating Research Into Action for Diabetes (TRIAD) Study
Ferrara et al.
Diabetes Care 2009;32:269-274.
ABSTRACT | FULL TEXT  

Cost-effectiveness of atrial fibrillation catheter ablation
Andrikopoulos et al.
Europace 2009;11:147-151.
ABSTRACT | FULL TEXT  

Omega-3 polyunsaturated fatty acids inhibit transient outward and ultra-rapid delayed rectifier K+currents and Na+current in human atrial myocytes
Li et al.
Cardiovasc Res 2009;81:286-293.
ABSTRACT | FULL TEXT  

Epidemiology of ischemic stroke from atrial fibrillation in Dijon, France, from 1985 to 2006
Bejot et al.
Neurology 2009;72:346-353.
ABSTRACT | FULL TEXT  

Heart Disease and Stroke Statistics--2009 Update: A Report From the American Heart Association Statistics Committee and Stroke Statistics Subcommittee
WRITING GROUP MEMBERS et al.
Circulation 2009;119:e21-e181.
FULL TEXT  

Obstructive sleep apnoea risk profile and the risk of recurrence of atrial fibrillation after catheter ablation
Tang et al.
Europace 2009;11:100-105.
ABSTRACT | FULL TEXT  

Potentially Preventable Strokes in High-Risk Patients With Atrial Fibrillation Who Are Not Adequately Anticoagulated
Gladstone et al.
Stroke 2009;40:235-240.
ABSTRACT | FULL TEXT  

Pharmacokinetics of Novel Atrial-Selective Antiarrhythmic Agent Vernakalant Hydrochloride Injection (RSD1235): Influence of CYP2D6 Expression and Other Factors
Mao et al.
J Clin Pharmacol 2009;49:17-29.
ABSTRACT | FULL TEXT  

CHAPTER 29 Atrial Fibrillation
Camm et al.
ESC Textbook of Cardiovascular Medicine 2009;2:med-9780199566990-chapter-med-9780199566990-chapter.
ABSTRACT | FULL TEXT  

Treatment of atrial fibrillation
Bajpai et al.
Br Med Bull 2008;0:ldn046v1-20.
ABSTRACT | FULL TEXT  

Incidence of Atrial Fibrillation in Relation to Changing Heart Rate Over Time in Hypertensive Patients: The LIFE Study
Okin et al.
Circ Arrhythm Electrophysiol 2008;1:337-343.
ABSTRACT | FULL TEXT  

Ischaemic stroke subtypes and associated risk factors: a French population based study
Bejot et al.
J. Neurol. Neurosurg. Psychiatry 2008;79:1344-1348.
ABSTRACT | FULL TEXT  

Experimental Model of Warfarin-Associated Intracerebral Hemorrhage
Foerch et al.
Stroke 2008;39:3397-3404.
ABSTRACT | FULL TEXT  

Association of rs2200733 at 4q25 with atrial flutter/fibrillation diseases in an Italian population
Viviani Anselmi et al.
Heart 2008;94:1394-1396.
ABSTRACT | FULL TEXT  

The impact of statin use on atrial fibrillation
Sanchez-Quinones et al.
QJM 2008;101:845-861.
ABSTRACT | FULL TEXT  

Comparison of the Impact of the Atrial Fibrillation Follow-Up Investigation of Rhythm Management Trial on Prescribing Patterns: A Time-Series Analysis
Choudhry et al.
The Annals of Pharmacotherapy 2008;42:1563-1572.
ABSTRACT | FULL TEXT  

From computers to ubiquitous computing by 2010: health care
Aziz et al.
Phil Trans R Soc A 2008;366:3805-3811.
ABSTRACT | FULL TEXT  

Racial/Ethnic Differences in Ischemic Stroke Rates and the Efficacy of Warfarin Among Patients With Atrial Fibrillation
Shen et al.
Stroke 2008;39:2736-2743.
ABSTRACT | FULL TEXT  

Epicardial Ultrasonic Ablation of Atrial Fibrillation During Concomitant Cardiac Surgery Is a Valid Option in Patients With Ischemic Heart Disease
Groh et al.
Circulation 2008;118:S78-S82.
ABSTRACT | FULL TEXT  

Prevention of Atrial Fibrillation With 3-Hydroxy-3-Methylglutaryl Coenzyme A Reductase Inhibitors
Adam et al.
Circulation 2008;118:1285-1293.
FULL TEXT  

Epicardial Pulmonary Vein Isolation: A Long-Term Histologic and Imaging Animal Study Comparing Cryothermy Versus Radiofrequency
Rahmanian et al.
Ann. Thorac. Surg. 2008;86:849-856.
ABSTRACT | FULL TEXT  

How to assess the efficacy of catheter ablation of atrial fibrillation?
Martignani et al.
Eur Heart J 2008;29:2183-2184.
FULL TEXT  

Alternatives to warfarin in atrial fibrillation: drugs and devices
Bayard et al.
Heart 2008;94:1113-1116.
FULL TEXT  

Role of transoesophageal echocardiography in evaluating the effect of catheter ablation of atrial fibrillation on anatomy and function of the pulmonary veins
De Piccoli et al.
Europace 2008;10:1079-1084.
ABSTRACT | FULL TEXT  

Mechanisms by which atrial fibrillation-associated mutations in the S1 domain of KCNQ1 slow deactivation of IKs channels
Restier et al.
J. Physiol. 2008;586:4179-4191.
ABSTRACT | FULL TEXT  

New-onset atrial fibrillation is an independent predictor of in-hospital mortality in hospitalized heart failure patients: results of the EuroHeart Failure Survey
Rivero-Ayerza et al.
Eur Heart J 2008;29:1618-1624.
ABSTRACT | FULL TEXT  

The Effect of Comorbid Illness and Functional Status on the Expected Benefits of Intensive Glucose Control in Older Patients with Type 2 Diabetes: A Decision Analysis
Huang et al.
ANN INTERN MED 2008;149:11-19.
ABSTRACT | FULL TEXT  

Antithrombotic Therapy in Atrial Fibrillation: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition)
Singer et al.
Chest 2008;133:546S-592S.
ABSTRACT | FULL TEXT  

Atrial Fibrillation and Isolated Systolic Hypertension: The Systolic Hypertension in the Elderly Program and Systolic Hypertension in the Elderly Program-Extension Study
Vagaonescu et al.
Hypertension 2008;51:1552-1556.
ABSTRACT | FULL TEXT  

Catheter Ablation for Atrial Fibrillation in Patients With Obesity
Cha et al.
Circulation 2008;117:2583-2590.
ABSTRACT | FULL TEXT  

Cardiac Disease in Chronic Obstructive Pulmonary Disease
Falk et al.
Proc Am Thorac Soc 2008;5:543-548.
ABSTRACT | FULL TEXT  

Review of A Large Clinical Series: Paroxysmal Atrial Fibrillation in Critically Ill Patients With Sepsis
Salman et al.
J Intensive Care Med 2008;23:178-183.
ABSTRACT  

Catheter ablation of paroxysmal atrial fibrillation improves cardiac function: a prospective study on the impact of atrial fibrillation ablation on left ventricular function assessed by magnetic resonance imaging
Lutomsky et al.
Europace 2008;10:593-599.
ABSTRACT | FULL TEXT  

Risks and Benefits of Oral Anticoagulation Compared With Clopidogrel Plus Aspirin in Patients With Atrial Fibrillation According to Stroke Risk: The Atrial Fibrillation Clopidogrel Trial With Irbesartan for Prevention of Vascular Events (ACTIVE-W)
Healey et al.
Stroke 2008;39:1482-1486.
ABSTRACT | FULL TEXT  

Antithrombotic treatment in atrial fibrillation
Lip and Boos
Postgrad. Med. J. 2008;84:252-258.
ABSTRACT | FULL TEXT  

The non-synonymous coding IKr-channel variant KCNH2-K897T is associated with atrial fibrillation: results from a systematic candidate gene-based analysis of KCNH2 (HERG)
Sinner et al.
Eur Heart J 2008;29:907-914.
ABSTRACT | FULL TEXT  

Costs of atrial fibrillation in five European countries: results from the Euro Heart Survey on atrial fibrillation
Ringborg et al.
Europace 2008;10:403-411.
ABSTRACT | FULL TEXT  

Mortality in patients with atrial fibrillation: improving or not?
Taggar et al.
Europace 2008;10:389-390.
FULL TEXT  

Use of Anticoagulation in Elderly Patients with Atrial Fibrillation Who Are at Risk for Falls
Garwood and Corbett
The Annals of Pharmacotherapy 2008;42:523-532.
ABSTRACT | FULL TEXT  

Oral Anticoagulants Versus Antiplatelet Therapy for Preventing Stroke in Patients With Nonvalvular Atrial Fibrillation and No History of Stroke or Transient Ischemic Attacks
Aguilar and Hart
Stroke 2008;39:1399-1400.
FULL TEXT  

Metabolic Syndrome and Risk of Development of Atrial Fibrillation: The Niigata Preventive Medicine Study
Watanabe et al.
Circulation 2008;117:1255-1260.
ABSTRACT | FULL TEXT  

Influence of diabetes on the maintenance of sinus rhythm after a successful direct current cardioversion in patients with atrial fibrillation
Soran et al.
QJM 2008;101:181-187.
ABSTRACT | FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2001 American Medical Association. All Rights Reserved.